Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albert Murtha

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
International Journal of Radiation Oncology, Biology, Physics|May 10, 2022
Conventional Versus Hypofractionated Radiation for High-Risk Prostate Cancer Patients (CHIRP): 24-Month Patient-Reported Outcomes of the Randomized Phase 2 CHIRP TrialFan Yang, Sunita Ghosh, Don Yee, et al.
International Journal of Radiation Oncology, Biology, Physics|April 28, 2009
Acute toxicity in high-risk prostate cancer patients treated with androgen suppression and hypofractionated intensity-modulated radiotherapyNadeem Pervez, Cormac Small, Marc MacKenzie, et al.
American Journal of Clinical Oncology|October 1, 2014
Late Toxicity and Outcomes in High-risk Prostate Cancer Patients Treated With Hypofractionated IMRT and Long-term Androgen Suppression TreatmentNadeem Pervez, Alex Boychak, Claudia S Drodge, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
International Journal of Radiation Oncology, Biology, Physics|May 10, 2022
Conventional Versus Hypofractionated Radiation for High-Risk Prostate Cancer Patients (CHIRP): 24-Month Patient-Reported Outcomes of the Randomized Phase 2 CHIRP TrialFan Yang, Sunita Ghosh, Don Yee, et al.
International Journal of Radiation Oncology, Biology, Physics|April 28, 2009
Acute toxicity in high-risk prostate cancer patients treated with androgen suppression and hypofractionated intensity-modulated radiotherapyNadeem Pervez, Cormac Small, Marc MacKenzie, et al.
American Journal of Clinical Oncology|October 1, 2014
Late Toxicity and Outcomes in High-risk Prostate Cancer Patients Treated With Hypofractionated IMRT and Long-term Androgen Suppression TreatmentNadeem Pervez, Alex Boychak, Claudia S Drodge, et al.
Pageof 4